Get the Daily Brief
Eurofins CDMO Alphora announced participation in an international NextGen ADC consortium to develop high‑yield expression vectors and peptide linker tags aimed at simplifying antibody‑drug conjugate (ADC) production, backed by NRC IRAP advisory services. The initiative pairs Eurofins’ manufacturing expertise with Daresbury Proteins’ protein expression tech to reduce ADC conjugation steps and cost. Separately, Alphora launched an AI‑powered salt and co‑crystal screening platform to accelerate solid‑state selection for APIs. The machine‑learning tool promises more accurate predictions of salt and co‑crystal formation, shortening development timelines. Together these moves signal a CDMO doubling down on integrated digital and process innovations to capture rising ADC and complex biologics demand.